Cirrhosis of the Liver (DBCOND0056665)

Identifiers

Synonyms
Hepatic Cirrhoses / Hepatic Cirrhosis / Liver Cirrhoses / Cirrhoses, Liver / Cirrhosis of Liver / Cirrhosis, Liver / Cirrhosis / Liver Cirrhosis / Unspecified cirrhosis of liver / Cirrhosis of liver (disorder) / Cirrhosis liver / Hepatic cirrhosis NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Ademetionine
S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as...
Buthiazide
A diuretic indicated in the treatment of edema caused by congestive heart failure, as well as hepatic and renal diseases.
No drug targets
Chlorthalidone
A diuretic used to treat hypertension or edema caused by heart failure, renal failure, hepatic cirrhosis, estrogen therapy, and other conditions.
Etacrynic acid
A diuretic used to treat ascites and edema in congestive heart failure, liver cirrhosis, and renal disease.
Furosemide
A loop diuretic used to treat hypertension and edema in congestive heart failure, liver cirrhosis, renal disease, and hypertension.
Glecaprevir
A Hepatitis C NS3/4A protease inhibitor used to treat Hepatitis C.
Hydrochlorothiazide
A thiazide diuretic used to treat edema associated with a number of conditions, and hypertension.
Hydroflumethiazide
A thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure and liver cirrhosis.
Ledipasvir
A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Methyclothiazide
A diuretic drug used to treat hypertension and edema caused by heart failure, renal conditions, treatment with corticosteroids, and estrogen therapy.
Pibrentasvir
A Hepatitis C NS5A inhibitor used to treat Hepatitis C.
Polythiazide
A thiazide diuretic used in the management of hypertension and treatment of edema.
Silibinin
A flavonolignan with hepatoprotective effects used to treat toxic liver damage and as an adjunct in the management of chronic conditions such as cirrhosis and hepatitis.
Sodium bisulfite
An ingredient in parenteral nutrition products for patients with severe liver disorders.
No drug targets
Sofosbuvir
A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Spironolactone
An aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism.
Triamterene
A potassium-sparing diuretic used in the treatment of edema and in the management of hypertension.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00006164
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatmentprevention3completed
NCT00698464
Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Functionother1completed
NCT06355479
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemiatreatment3completed
NCT04682847
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersNot AvailableNot Availableactive_not_recruiting
NCT00896597
Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosisdiagnostic1completed
NCT03804593
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT05904470
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVtreatment2active_not_recruiting
NCT01349335
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascitestreatment2completed
NCT02778425
The Treatment of Hepatocirrhosis and Portal HypertensionNo drug interventionstreatmentNot Availablecompleted
NCT01349348
Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascitestreatment3completed
NCT01359462
Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosistreatment1completed
NCT03712280
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)treatment2completed
NCT00857480
Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillindiagnostic1completed
NCT00856869
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteersdiagnostic1 / 2completed
NCT02652351
Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosistreatment1unknown_status
NCT02138253
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCVtreatment2completed
NCT02230683
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertensiontreatment2completed
NCT01135628
Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic EncephalopathytreatmentNot Availablecompleted
NCT02230670
A Study of IDN-6556 in Subjects With Liver Cirrhosistreatment2completed
NCT02171949
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver DiseasesNo drug interventionstreatment2unknown_status
NCT00856713
Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteersdiagnostic1completed
NCT00794482
Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.diagnostic3completed
NCT03420768
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis CNo drug interventionstreatment2completed
NCT03486912
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosistreatment2completed
NCT02163512
Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory AscitesNo drug interventionsNot AvailableNot Availablecompleted
NCT03445208
A Study of Experimental Medication BMS-986036 Given to Healthy Participantstreatment1completed
NCT04525833
Liver Disease and Other Systemic DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03981211
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject DrugstreatmentNot Availablerecruiting
NCT04089878
"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR ShuntNo drug interventionstreatmentNot Availableunknown_status
NCT04140578
Antibiotic Prophylaxis in Patients Undergoing GVOprevention4recruiting
NCT03855709
Antibiotic-resistant Bacterial Infection of Hepatic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04357600
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis BNo drug interventionstreatment1 / 2unknown_status
NCT03759158
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO TrialtreatmentNot Availablecompleted
NCT03083925
Viatorr CX Case-control Study for Complications of Portal HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT03780673
Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Developmenttreatment2 / 3completed
NCT04212273
Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCCNo drug interventionsdiagnosticNot Availablerecruiting
NCT02484573
Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)treatmentNot Availableunknown_status
NCT03871894
Indirect Calorimeter Based Study in Patients With Liver CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT03694691
Developing Viability Index for Machine Perfused LiversNo drug interventionsdiagnosticNot Availablerecruiting
NCT03219372
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrenceprevention2terminated
NCT03483272
MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)No drug interventionsNot AvailableNot Availablecompleted
NCT04191369
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.No drug interventionsdiagnosticNot Availableunknown_status
NCT03827681
To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.No drug interventionstreatmentNot Availableunknown_status
NCT04288323
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosisscreening4recruiting
NCT04474743
Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04242979
Assessing of Physicians' Knowledge About International Guidelines of Albumin Use in Patients With Liver CirrhosisNo drug interventionsscreeningNot Availableunknown_status
NCT04057287
Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)No drug interventionsNot AvailableNot Availablerecruiting
NCT03837145
Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.No drug interventionsNot AvailableNot Availableunknown_status
NCT03171805
The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric VaricestreatmentNot Availableunknown_status
NCT04131205
Role of MRI in Detection of Minimal Hepatic EncephalopathyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03868397
Preoperative Portal and Splanchnic Flow Measurement Using MRINo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT03072615
Role of SWE-change After TIPS in the Prediction of Prognosis After TIPSNo drug interventionsNot AvailableNot Availablecompleted
NCT04198259
Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPSNo drug interventionspreventionNot Availableunknown_status
NCT04340999
Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03624517
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varicestreatment4recruiting
NCT03443934
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03139058
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and NeckNo drug interventionsotherNot Availableunknown_status
NCT03878563
Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: a Pilot Trial (AMBIC)No drug interventionsNot AvailableNot Availableterminated
NCT04212286
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCCNo drug interventionsdiagnosticNot Availablecompleted
NCT04160039
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care UnitNo drug interventionstreatmentNot Availableterminated
NCT04254822
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic PatientspreventionNot Availableunknown_status
NCT03156426
Prognostic Biomarkers For Acute Kidney Injury In Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03620474
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosistreatment1 / 2completed
NCT04013074
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.No drug interventionstreatmentNot Availableunknown_status
NCT02965131
The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity and Cognitive FunctionNo drug interventionsdiagnosticNot Availablecompleted
NCT03172273
Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory AscitesNo drug interventionstreatmentNot Availablerecruiting
NCT03283176
Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without RibavirinNo drug interventionsNot AvailableNot Availablecompleted
NCT03650660
Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert GastroenterologistNo drug interventionsNot AvailableNot Availableterminated
NCT04113629
Simplified Monitoring Myanmar SM2 StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT02367092
Exercise Intervention in Liver Transplant PatientsNo drug interventionstreatmentNot Availablecompleted
NCT04345640
The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.No drug interventionsNot AvailableNot Availableunknown_status
NCT04072601
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosistreatment4terminated
NCT03198104
Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRINo drug interventionsNot AvailableNot Availablecompleted
NCT04326946
International Alfapump Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03746210
Non-Invasive Characterization of Focal Liver Lesions in Liver CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03222167
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1btreatment3unknown_status
NCT03150459
Simvastatin Plus Rifaximin in Decompensated Cirrhosistreatment2completed
NCT03776955
Beta-blockers for Oesophageal Varicesprevention4recruiting
NCT05178303
Composition for Treating Cirrhosis and Liver Cancer (SB-1121)No drug interventionstreatmentNot Availablecompleted
NCT02862249
Trial of Faecal Microbiota Transplantation in CirrhosisNo drug interventionsother3completed
NCT01573325
HRQoL in the Low MELD Pre-tx PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT02809248
The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)No drug interventionsdiagnosticNot Availablewithdrawn
NCT04116242
MERTK Signalling in Monocytes/Macrophages in Patients With Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02608658
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With AscitesNo drug interventionssupportive_careNot Availablecompleted
NCT04243148
Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial InterventiontreatmentNot Availablecompleted
NCT06121492
Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopeniatreatment3enrolling_by_invitation
NCT01722578
L-ornithine L-aspartate in Overt Hepatic Encephalopathytreatment4completed
NCT01446666
Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04976764
The Correlation Between Cirrhotic Cardiomyopathy and Perioperative Cardiovascular Events in Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT06437964
Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal BleedingNo drug interventionstreatmentNot Availablerecruiting
NCT06136221
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver DiseaseNo drug interventionssupportive_careNot Availablerecruiting
NCT04664621
HepQuant to Predict Hepatic Encephalopathy After TIPSNo drug interventionsdiagnosticNot Availablewithdrawn
NCT04332484
Global Coagulation Assessment in Cirrhosis and ACLFNo drug interventionsNot AvailableNot Availablecompleted
NCT05551884
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics TechnologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04216784
Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patientstreatment4terminated
NCT04867954
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00244751
Antifibrotic Activity Of GI262570 In Chronic Hepatitis C SubjectsNo drug interventionstreatment2completed
NCT04383951
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH CirrhosisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03388151
Propofol Versus Midazolam for Lower Gastrointestinal Endoscopytreatment3unknown_status
NCT05420753
Body Composition Changes After TIPS and Associated Clinical OutcomesNo drug interventionstreatment0recruiting
NCT04588077
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosisprevention4recruiting
NCT04244877
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotilitytreatment3withdrawn
NCT03850977
Is There an Association Between Chronic Pancreatitis and Pulmonary FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT04221347
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCNo drug interventionsNot AvailableNot Availableunknown_status
NCT04463745
Organ Dysfunction Associated With Intra Abdominal Pressures in Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04767945
Cirrhosis Registry of Hospitalized PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03415698
G-CSF in Decompensated Cirrhosis: an Open Label Trialtreatment2 / 3unknown_status
NCT03695705
Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosisprevention3completed
NCT06315361
DIAbetes and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05346393
HRS-AKI Treatment With TIPS in Patients With CirrhosistreatmentNot Availablerecruiting
NCT04195971
Dual Arterial Phase Liver CT in Patients With Suspected Portal HypertensionNo drug interventionsdiagnosticNot Availableunknown_status
NCT05441878
20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotensiontreatment4unknown_status
NCT05128578
Improving Pain Management and Opioid Safety for Patients With CirrhosisNo drug interventionshealth_services_researchNot Availablecompleted
NCT05490888
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhoticstreatment1recruiting
NCT03152188
Oral Fecal Transplant in CirrhosisNo drug interventionsprevention1completed
NCT03834285
Liver Disease in PregnancyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03995537
Monocytic Expression of HLA-DR After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04051437
Plasma Exchange in Acute on Chronic Liver FailureNo drug interventionstreatment3unknown_status
NCT06531200
Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep LearningNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05287100
To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.treatmentNot Availablecompleted
NCT04845659
Avatrombopaq In Patients With Cirrhosisprevention4unknown_status
NCT03892070
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled TrialNo drug interventionstreatmentNot Availableunknown_status
NCT04246970
Prehabilitation and Posttransplant Training Program in Liver TransplantationNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT03354299
Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis PatientNo drug interventionssupportive_careNot Availablecompleted
NCT04155099
Investigational Microbiota Restoration Therapeutic for Hepatic EncephalopathyNo drug interventionstreatment2terminated
NCT05166499
HMB Enriched Amino Acids to Reverse Muscle Loss in CirrhosisNo drug interventionsotherNot Availablerecruiting
NCT04267406
ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT05503836
Assessment of Severity of Liver Disease Before SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04502719
Comparison of Nutritional Screening Tools in Liver Cirrhosis PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05124041
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced CoagulopathyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02254434
A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditionsother1completed
NCT05304234
Liver Cancer Disparities in American Indian and Alaska Native PersonsNo drug interventionsscreening2recruiting
NCT05325424
The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT05928624
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis PatientsNo drug interventionsotherNot Availablerecruiting
NCT06039696
Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis InfectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04790435
Acute-On-Chronic Liver Failure In Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05028322
Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimenprevention2not_yet_recruiting
NCT04460222
Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled TrialNo drug interventionstreatmentNot Availablecompleted
NCT04591522
Fecal Microbiota Transplantation in CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT05500222
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)treatment3recruiting
NCT05259930
Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT05683548
Replicor Compassionate Access ProgramNot AvailableNot Availableavailable
NCT04044248
TIPS Plus Transvenous Obliteration for Gastric VaricesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05315557
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C TrialtreatmentNot Availableunknown_status
NCT06537466
Ketogenic Diet in MASLD-related cACLDNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06095466
Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and HistologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05604274
Longitudinal Monitoring of Stool CharacteristicsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04111120
Heparin Like Effect in Acute Variceal BleedingNo drug interventionsNot AvailableNot Availableunknown_status
NCT05786482
Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical ConditionsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03726827
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsNo drug interventionsNot AvailableNot Availablecompleted
NCT05033327
Feasibility of an App-based Nutrition & Exercise Program in CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT04530760
Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical VentilationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04252794
Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT05338294
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT06267794
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.treatment2completed
NCT04326491
The Utility of Breath Biopsy as a Screening Tool for HCCNo drug interventionsNot AvailableNot Availablecompleted
NCT06455280
SIPLIZUMAB in AILD and LTtreatment1not_yet_recruiting
NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06248580
Find HDV and Determine Its Status in TurkeyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02752529
The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of MulticentertreatmentNot Availableunknown_status
NCT04055389
Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosisprevention1withdrawn
NCT03309592
Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertensiontreatment4withdrawn
NCT05196867
Liver Cancer Prevention Randomized Control TrialNo drug interventionspreventionNot Availablerecruiting
NCT05433467
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical ResectionNo drug interventionstreatmentNot Availablerecruiting
NCT06526104
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosistreatment2not_yet_recruiting
NCT03973372
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS PlacementNo drug interventionsNot AvailableNot Availablerecruiting
NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablerecruiting
NCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)No drug interventionsNot AvailableNot Availablerecruiting
NCT05982769
Molecular Mechanism of Exercise in CirrhosisNo drug interventionsotherNot Availablerecruiting
NCT05339269
The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT03800069
Validation of Point of Care Liver Function TestsNo drug interventionsNot AvailableNot Availableterminated
NCT04199910
4beta-hydroxycholesterol in CirrhosisNo drug interventionsNot AvailableNot Availablesuspended
NCT05059795
Volume Resuscitation in Cirrhosis With Sepsis Induced HypotensionNot AvailableNot Availablerecruiting
NCT04643795
Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjectstreatment1completed
NCT04218695
Prophylactic Antibiotics in Admitted Cirrhoticsprevention4completed
NCT06296095
To Evaluate the Clinical Study of CUD005 Injection in Patients With CirrhosisNo drug interventionstreatment1enrolling_by_invitation
NCT05794555
LiveSMART Trial to Prevent Falls in Patients With Cirrhosistreatment3recruiting
NCT06224023
Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver FailureNo drug interventionsNot AvailableNot Availablerecruiting
NCT05700708
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory AscitesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04620538
Volatile Organic Compounds for the Assessment of Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05218538
Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.No drug interventionsNot AvailableNot Availableunknown_status
NCT04953143
LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT04073290
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactuloseprevention4unknown_status
NCT03236090
Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisNo drug interventionstreatmentNot Availablewithdrawn
NCT04873102
Danazol for Treatment of Cytopenias in Patients With Cirrhosistreatment2recruiting
NCT04814602
Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairmentother0completed
NCT04172779
Erlotinib for Hepatocellular Carcinoma Chemopreventionprevention2not_yet_recruiting
NCT04111133
Ivabradine in Cirrhotic CardiomyopathytreatmentNot Availablerecruiting
NCT03658551
Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal EndoscopyNo drug interventionsNot AvailableNot Availableterminated
NCT03070353
Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injurytreatment2 / 3completed
NCT03605147
The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT05872698
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.prevention4recruiting
NCT05128305
Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its ComplicationNo drug interventionstreatment3unknown_status
NCT03941405
Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)treatment2unknown_status
NCT04076605
Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive ProceduresNo drug interventionsNot AvailableNot Availablecompleted
NCT05184283
Utilization of MAsS in Patients Undergoing LT for HCCNo drug interventionsNot AvailableNot Availableterminated
NCT05237583
Prehabilitation for Patients Awaiting Liver TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT05793983
S100A8/A9 and Innate Immunity in Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05107271
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06293378
Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.treatmentNot Availablerecruiting
NCT05687409
Synbiotics Interventions for Managing Cirrhosis and Its Complicationstreatment4completed
NCT04466709
The Relationship Betweensarcopenia And Myosteatosis With The Natural History Of Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05475015
3D-MRE for Assessing Cirrhosis and Portal HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03120637
Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Bluesupportive_care4completed
NCT05325437
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT04957875
Timing of Endoscopy for Acute Variceal Bleeding in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01438970
Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory FunctionNo drug interventionstreatment2unknown_status
NCT03969199
Give a MANNA a Fish, Teach a MANNA to FishNo drug interventionssupportive_careNot Availablewithdrawn
NCT05828836
Allopurinol and Quality of Life in Liver Cirrhosistreatment2 / 3completed
NCT03172013
Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03158818
Chronic Hepatitis B Virus Infection in ZambiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05093218
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.No drug interventionstreatmentNot Availableunknown_status
NCT06431919
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and SurvivaltreatmentNot Availablenot_yet_recruiting
NCT05698134
Rotational Thromboelastometry (ROTEM™) Guided Transfusion for Elective Procedures in Patients With Cirrhosis (REduCe): An Open Label Randomized Controlled Trial.No drug interventionstreatmentNot Availablerecruiting
NCT04195724
Microbiome Translocation in Different Circulatory Compartments in Decompensated CirrhosisNo drug interventionsotherNot Availableunknown_status
NCT04358016
Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleedingprevention4completed
NCT04640116
TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesNo drug interventionstreatmentNot Availableunknown_status
NCT04178096
Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis CareNo drug interventionshealth_services_researchNot Availablecompleted
NCT05740358
Liver Cirrhosis Network Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03969186
Telehealth Intervention in CirrhoticsNo drug interventionssupportive_careNot Availablecompleted
NCT05434286
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney InjuryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05583539
Thromboelastography Guided Blood Product Transfusion for Upper Gastrointestinal Bleeding in CirrhosisNo drug interventionssupportive_careNot Availablewithdrawn
NCT06015022
EGCG for Hepatocellular Carcinoma Chemopreventionprevention2recruiting
NCT05998330
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver DiseaseNo drug interventionssupportive_careNot Availablerecruiting
NCT05202457
Cirrhotics Undergoing General SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT06149026
Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT04235166
Risk Assessment After Acute Upper Gastrointestinal Haemorrhage in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03736265
Carvedilol for Prevention of Esophageal Varices ProgressionpreventionNot Availableunknown_status
NCT04595474
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06231420
Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled TrialNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT04121520
Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter SurveyNo drug interventionsNot AvailableNot Availablecompleted
NCT04786782
The vPPG-detecting Software Guided Management of Cirrhotic Portal HypertensionNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05899231
Online Prehabilitation for Patients Awaiting Liver TransplantationNo drug interventionstreatmentNot Availablerecruiting
NCT05999773
SGLT-2 Inhibitors in the Treatment of AscitesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03437876
Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT04604860
Use of EL-FIT App to Promote Physical ActivityNo drug interventionstreatmentNot Availablecompleted
NCT03204591
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver InjuryNo drug interventionsNot AvailableNot Availableunknown_status
NCT05538962
Longitudinal Monitoring of Inflammation in CirrhosisNo drug interventionssupportive_careNot Availablecompleted
NCT04082780
Rifamycin in Minimal Hepatic Encephalopathytreatment2completed
NCT03846180
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal HemorrhageNot AvailableNot Availablecompleted
NCT06573229
LIver FRAilty Management IN Cirrhosis (LIFRAMIN)No drug interventionstreatmentNot Availablerecruiting
NCT05346029
Role of Sarcopenia and Nutritional/Physical Therapy Intervention in Post-TIPS Hepatic EncephalopathyNo drug interventionspreventionNot Availablerecruiting
NCT05047029
Myocardial Fibrosis and Inflammation in Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05832229
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United Statestreatment2recruiting
NCT04311489
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.treatment2terminated
NCT05651789
Carvedilol vs. Propranolol in Second Prophylaxis of Variceal BleedingpreventionNot Availablenot_yet_recruiting
NCT06511492
Longitudinal Surveillance of Rectal Colonization and Transmission by Resistant Bacteria in Acutely Decompensated CirrhosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06358092
Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal HypertensionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04175392
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitistreatment1 / 2terminated
NCT04592744
Angiotensin 2 for AKI After OLTprevention4enrolling_by_invitation
NCT03420144
Growth Hormone Therapy in Liver Cirrhosistreatment2 / 3completed
NCT04322201
Continuous Passive Paracentesis for Intra-abdominal HypertensionNo drug interventionstreatmentNot Availableunknown_status
NCT06174272
Transitional Care Program for Fluid Overload in CirrhosisNo drug interventionssupportive_careNot Availablerecruiting
NCT04576572
Comparison of Criteria for Liver Transplantation in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT03208868
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in CirrhosisNo drug interventionspreventionNot Availablerecruiting
NCT04581369
Cirrhosis Medical HomeNo drug interventionshealth_services_researchNot Availablecompleted
NCT04493346
Shear Wave ElastographyNo drug interventionsNot AvailableNot Availablecompleted
NCT04243681
Combination of Autologous MSC and HSC Infusion in Patients With Decompensated CirrhosisNo drug interventionstreatment4completed
NCT05623150
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic SyndromeNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03878550
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06525623
Initial Resuscitation for Acute Kidney Injury in CirrhosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04149223
Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation TrialNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05729438
Nutritional Assesment in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00742690
Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrometreatment2 / 3unknown_status
NCT01300390
Assessment of Endothelial Function, Apolipoproteins and AdiponectinNo drug interventionsNot AvailableNot Availablecompleted
NCT00450164
Secondary Prophylaxis After Variceal Bleeding in Non-Respondersprevention4completed
NCT01956864
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancerother1withdrawn
NCT02400164
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent AscitesNo drug interventionstreatmentNot Availablecompleted
NCT06307964
Intra-Hepatic Microbiota in Alcoholic HepatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02151864
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosistreatment1completed
NCT00287664
Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumintreatment4suspended
NCT01655121
Effect of High-protein High-fiber Diet in Patients With Autoimmune HepatitisNo drug interventionssupportive_careNot Availablecompleted
NCT03027921
Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver FibrosisNo drug interventionsscreeningNot Availableunknown_status
NCT00629421
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01072721
Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic FibrosisNo drug interventionsdiagnosticNot Availablecompleted
NCT02267421
Effects of Home Based Exercise Therapy in Early CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT01863121
Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00966121
Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal RebleedingNo drug interventionsprevention4unknown_status
NCT02321202
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancerprevention4completed
NCT02442284
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infectiontreatment3completed
NCT00888784
Secondary Prophylaxis Gastric Variceal BleedpreventionNot Availablecompleted
NCT06135584
Study on MAFLD-related Cirrhosis Prevention and Treatment StrategiestreatmentNot Availablenot_yet_recruiting
NCT04976543
Safety of Anticoagulant Therapy After Endoscopic Treatmenttreatment4completed
NCT02642003
To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosistreatment3completed
NCT04807803
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal HypertensionNo drug interventionspreventionNot Availablerecruiting
NCT02457403
Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and CoagulopathyNo drug interventionsdiagnosticNot Availablecompleted
NCT00043303
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosistreatment2completed
NCT01387503
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingNo drug interventionstreatmentNot Availablecompleted
NCT01458990
Proton Pump Inhibitors and Dysbiosis in CirrhosisdiagnosticNot Availablecompleted
NCT02401490
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathytreatment4unknown_status
NCT01403987
Improving Performance of Paracentesis in Medical Residency TrainingNo drug interventionsNot AvailableNot Availablecompleted
NCT01188733
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosisprevention1 / 2completed
NCT02451033
Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Studytreatment2 / 3completed
NCT02824354
Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.treatment3withdrawn
NCT05205954
HepHospital: A Hepatology Home Hospital Intervention for Patients With Advanced Liver DiseaseNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT01761851
Resting Energy Expenditure in Patients on the Waiting List for Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03416751
Fecal Microbial Transplant for Alcohol Misuse in CirrhosisNo drug interventionstreatment1completed
NCT02693951
Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric VaricespreventionNot Availableunknown_status
NCT02132351
Hepatic Fibrosis Non-invasive Methods QuestionnaireNo drug interventionsNot AvailableNot Availablecompleted
NCT03277651
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01603953
Bioelectrical Impedance Vector Analysis in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03654053
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosistreatment3active_not_recruiting
NCT00359853
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitisprevention4completed
NCT03676777
Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT05477277
Adverse Outcomes and Mortality in Liver TransplantNo drug interventionsdiagnosticNot Availablerecruiting
NCT02821377
Metabolic Effects of Furosemide +HSS in Refractory Ascitestreatment2completed
NCT06345547
Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03458845
Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal HerniaNo drug interventionsNot AvailableNot Availablecompleted
NCT02650245
Breath and Blood Ammonia Response to an Oral Protein ChallengeNo drug interventionsdiagnosticNot Availablecompleted
NCT02737345
Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT01192698
Intravenous Interferon During Liver TransplantNo drug interventionstreatmentNot Availablecompleted
NCT01686698
Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisNo drug interventionstreatment4completed
NCT00761098
Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)No drug interventionstreatment4unknown_status
NCT02534805
Patient Buddy App for the Prevention of Avoidable Readmission in CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05244005
Extubation Failure in Critically Ill Cirrhotic Patients.No drug interventionsNot AvailableNot Availableunknown_status
NCT03176797
Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRINo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT05413083
Evaluation of Cardiac Function in Acutely Decompensated CirrhosisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03045783
Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric VaricespreventionNot Availableunknown_status
NCT05782283
A Study to Detect Advanced Liver Disease Via AI-enabled ElectrocardiogramNo drug interventionsdiagnosticNot Availablerecruiting
NCT01387061
Resection for Multiple Hepatocellular Carcinomas (HCC)No drug interventionstreatmentNot Availablecompleted
NCT02774161
B-mode Ultrasound Imaging in Detecting Early Liver CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01114828
A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edematreatment3completed
NCT03853928
Probiotics in the Prevention of Hepatocellular Carcinoma in CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT06288828
The Efficacy of Aerobic Exercise Training on Autonomic Nervous System and Endothelial Function in Patients With Compensated CirrhosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02673411
Ultrasonography SWE for Hepatic Fibrosis EvaluationNo drug interventionsNot AvailableNot Availablecompleted
NCT01530711
Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Responsetreatment4unknown_status
NCT01208311
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundNo drug interventionsNot AvailableNot Availablecompleted
NCT05051293
Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and HypotensionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03777293
A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound ViscoelasticityNo drug interventionsdiagnosticNot Availableunknown_status
NCT00151671
Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerNo drug interventionsprevention2 / 3terminated
NCT02854371
Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRIdiagnostic4completed
NCT02935478
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver TransplantationNo drug interventionstreatmentNot Availablesuspended
NCT01992978
Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT03705078
"Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric VaricesNo drug interventionstreatmentNot Availablecompleted
NCT00312078
Effect of Yogurt on Minimal Hepatic EncephalopathyNo drug interventionstreatmentNot Availablecompleted
NCT05376488
Effect of Brief Dietary Intervention on Ammonia LevelsNo drug interventionssupportive_careNot Availablecompleted
NCT02173288
Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascitestreatment2 / 3completed
NCT04048707
Angiotensin 2 for Hepatorenal Syndrometreatment2withdrawn
NCT02758509
Impact of Antiviral Therapy on Gastroesophageal Varices.Not AvailableNot Availablecompleted
NCT04633356
EUS Guided Portal-systemic Pressure Gradient MeasurementNo drug interventionsdiagnostic1 / 2recruiting
NCT03084185
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .No drug interventionsNot AvailableNot Availableunknown_status
NCT01331785
Mechanism and the Effect of Midodrine on Portal Pressures in Patients With CirrhosistreatmentNot Availablewithdrawn
NCT02085915
Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT04155515
A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patientstreatment3completed
NCT05140837
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)No drug interventionsNot AvailableNot Availablerecruiting
NCT01447537
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT04446832
VACcination of LIver Transplantation CandidatesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03932552
Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)No drug interventionstreatmentNot Availablecompleted
NCT01283152
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.treatmentNot Availablecompleted
NCT06464952
Microbiome Modulation With Prebiotics in PTSD and CirrhosisNo drug interventionssupportive_careNot Availablerecruiting
NCT00275652
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.treatment3completed
NCT00603200
Effect of Large Volume Paracentesis on Fatigue in CirrhosisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03827200
A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosistreatment2terminated
NCT02184000
The Role of Strain Elastography in Staging Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05309200
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injurytreatment2completed
NCT01888900
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CNo drug interventionstreatment2completed
NCT02304159
Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhoticstreatment4completed
NCT05545670
Allopurinol to Prevent Cirrhosis Related Morbiditiesprevention2 / 3completed
NCT00252642
Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CtreatmentNot Availablecompleted
NCT05357599
The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated CirrhosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02427906
Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00076336
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosistreatment3completed
NCT01060813
Study of the Benefit of Exercise and Aminoacid Supplements in Cirrhotic PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00414713
Transfusion Requirements in Gastrointestinal (GI) BleedingNo drug interventionstreatment4unknown_status
NCT02180113
Spleen Stiffness Measurement With FibroScanNo drug interventionsdiagnosticNot Availablecompleted
NCT00179413
Study of Long-term Peg Intron vs. Colchicine in Non-responders.prevention4completed
NCT02017119
Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patientstreatment2completed
NCT01846819
Factors Associated With End Stage Liver DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT02465619
To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.No drug interventionsNot AvailableNot Availablewithdrawn
NCT01893541
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?prevention4completed
NCT02854241
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC SurveillanceNo drug interventionsscreeningNot Availableunknown_status
NCT03534141
Mild Hypothermia and Acute Kidney Injury in Liver TransplantationNo drug interventionspreventionNot Availableterminated
NCT00986817
Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumintreatment3completed
NCT03195634
WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver CirrhosisNot AvailableNot Availableunknown_status
NCT02705534
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1treatment3completed
NCT02484534
Thrombin Generation Test in Patient With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00926224
Fibroscan® and Its Dedicated Probes Efficiency in Obese PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT00048724
Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)treatment3completed
NCT01954524
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosistreatment1terminated
NCT04940416
Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT03438916
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05300516
Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal DisconnectionNo drug interventionspreventionNot Availablecompleted
NCT00905996
Primary Prophylaxis of Gastric Varix BleedpreventionNot Availablecompleted
NCT02313896
Cirrhosis Readmission Telehealth ProjectNo drug interventionspreventionNot Availableterminated
NCT03396796
Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal DisconnectionNo drug interventionspreventionNot Availablecompleted
NCT03027635
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosissupportive_careNot Availableterminated
NCT00741663
Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)treatment4completed
NCT06544863
Evaluation of Patient Care Support for Cirrhosis and/or Liver TransplantsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00742339
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrometreatment2 / 3terminated
NCT00906139
Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patientstreatment4unknown_status
NCT02475122
Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)No drug interventionsotherNot Availablecompleted
NCT00343122
Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus PolygelineNo drug interventionsNot AvailableNot Availableunknown_status
NCT05027425
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplanttreatment2recruiting
NCT03278925
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosisprevention1active_not_recruiting
NCT00368225
Transplant-Related Accelerated Progression of Hepatitis CNo drug interventionsNot AvailableNot Availablecompleted
NCT03447730
Safety, Tolerability and Pharmacodynamics of SYNB1020treatment1 / 2terminated
NCT01050530
A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edematreatment3completed
NCT03246048
Long Term Follow-up of Hepatitis C Cured PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02258048
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early CirrhosisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06000748
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsNo drug interventionstreatment2 / 3recruiting
NCT02908048
Extracellular RNA Markers of Liver Disease and CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03987048
Cirrhotic Patients With Septic ShockNo drug interventionsNot AvailableNot Availablecompleted
NCT00424957
Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT03585257
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)treatment2completed
NCT01687257
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensationtreatment2completed
NCT00772057
Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT)preventionNot Availablecompleted
NCT03564626
Health IT Generated PROs to Improve Outcomes in CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT05467826
Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosistreatment4unknown_status
NCT03625726
Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)screeningNot Availableunknown_status
NCT01578226
Procalcitonin in Cirrhotic Patients at High Risk for SepsisNo drug interventionsNot AvailableNot Availablecompleted
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT01551966
Esophageal Capsule Endoscopy in ChildrenNo drug interventionsdiagnosticNot Availablecompleted
NCT03123666
Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT02310165
Insertion Technique in Large Volume ParacentesisNo drug interventionstreatmentNot Availablecompleted
NCT03025074
Blood Collection Biorepository for Liver Disease ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT01205074
¹³C-Methacetin Breath Test (MBT) Methodology StudyNot Available2 / 3unknown_status
NCT00966082
EBL Versus EBL and Propranolol for the Prevention of Variceal Rebleeding in Pts With Previous Variceal TreatmentNo drug interventionsprevention4unknown_status
NCT05045482
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Diseasetreatment1recruiting
NCT02154282
iPod Games in Hepatic EncephalopathyNo drug interventionstreatmentNot Availablecompleted
NCT02372682
Shear Wave Sonoelastography in Pediatric Liver FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06277882
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosisprevention4recruiting
NCT04053231
Hepatocarcinoma Recurrence on the Liver Study - Part2No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04788173
Assessment Of Lipid Profile In Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01165073
Short Term Feeding for Asian Patients With Liver CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT06549673
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological FactorsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04915573
Antimicrobial Resistance in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04179773
Chemotherapy and Liver Cirrhosis in Frequently-associated CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT05967273
CirrhosisRx CDS SystemNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT04074473
Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varicestreatment4unknown_status
NCT01492127
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT01923376
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)treatmentNot Availablewithdrawn
NCT05014594
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCTtreatment2unknown_status
NCT03107091
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascitestreatment2completed
NCT06420791
The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma:a Two-center Retrospective Cohort Study in ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT00594191
Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertensiontreatment2completed
NCT00125762
FibroScan in Patients With Hepatitis B and C Presenting for Liver BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT02273362
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liverprevention1 / 2completed
NCT01242280
Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding.No drug interventionstreatment3completed
NCT00493480
Danish Carvedilol Study in Portal Hypertensionprevention3completed
NCT02596880
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhoticstreatment3completed
NCT05028829
Safety and Efficacy of Atorvastatin v. Placebo on HCC Riskprevention2recruiting
NCT03599492
The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut MicrobiotaNo drug interventionsNot AvailableNot Availablecompleted
NCT00701792
Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT02238444
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomyprevention4unknown_status
NCT01080144
Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal EncephalopathyNo drug interventionsdiagnosticNot Availablecompleted
NCT03507140
Microbiota Study in Liver Transplanted PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00999167
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathytreatment2completed
NCT01350167
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver DiseaseNo drug interventionsscreeningNot Availableunknown_status
NCT03720067
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertensiontreatment2 / 3unknown_status
NCT02439567
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)No drug interventionsotherNot Availablecompleted
NCT02143401
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumorstreatment1active_not_recruiting
NCT00513201
Lyspro Insulin vs Regular Insulin in Cirrhotic PatientsNot Available4completed
NCT05541601
Prospective Cohort for Early Detection of Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03407001
Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosisscreening0completed
NCT03493204
Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialNo drug interventionstreatmentNot Availablecompleted
NCT03121404
Mechanisms of Malnutrition in Cirrhosis With Portosystemic ShuntingNo drug interventionsNot AvailableNot Availablerecruiting
NCT01292304
Tolvaptan for Ascites in Cirrhotic Patientstreatment4completed
NCT04153604
Doxycycline for the Prevention of Spontaneous Bacterial PeritonitisNot AvailableNot Availablecompleted
NCT02272504
A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using BiomarkersNo drug interventionsNot AvailableNot Availablecompleted
NCT05486572
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRINo drug interventionspreventionNot Availablerecruiting
NCT03743272
Repeatability and Reproducibility of Multiparametric MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT05260268
Technology Enabled Strategies to Promote Treatment Adherence in Liver TransplantNo drug interventionssupportive_careNot Availablerecruiting
NCT02983968
Use of the French Healthcare Insurance DatabaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03870568
Functional Assessment in Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05769868
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatmentsdiagnostic3recruiting
NCT05689268
EUS-PPG vs HVPG in Portal HypertensionNo drug interventionsdiagnosticNot Availablecompleted
NCT01267669
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal BleedingtreatmentNot Availablecompleted
NCT00244569
Development of a Breath Test for Monitoring Patients With Liver Diseasediagnostic3completed
NCT01556646
Effect of Tolvaptan on Cognitive Function in Cirrhosistreatment3completed
NCT02256046
Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal VaricesNo drug interventionsscreeningNot Availableunknown_status
NCT01455246
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitistreatment2 / 3terminated
NCT03706846
Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear FluidsNo drug interventionsotherNot Availablecompleted
NCT02643212
Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosistreatment3unknown_status
NCT03363412
Tips Underdilatation in Patients With CirrhosisNo drug interventionspreventionNot Availableunknown_status
NCT02991612
Rifaximin in Patients With Gastroesophageal Variceal BleedingtreatmentNot Availablecompleted
NCT00820781
Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric VaricesNo drug interventionstreatmentNot Availablecompleted
NCT01842581
The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathytreatment4completed
NCT01196481
Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.preventionNot Availablecompleted
NCT02964195
Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal BleedingpreventionNot Availableunknown_status
NCT00596414
Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trialtreatment4completed
NCT05095714
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.No drug interventionsscreeningNot Availablenot_yet_recruiting
NCT02247414
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnectiontreatment4completed
NCT01882855
Effect of Music on Attention and Prospective Memory in Hepatic EncephalopathyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03908255
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinomasupportive_care2withdrawn
NCT05304455
Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal DisconnectionpreventionNot Availablecompleted
NCT00802555
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)treatment1completed
NCT04645550
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)prevention4completed
NCT02356250
A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04939350
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021No drug interventionsNot AvailableNot Availablecompleted
NCT04836923
LIFT Intervention in Liver Transplant CandidatesNo drug interventionspreventionNot Availablerecruiting
NCT02344823
Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosistreatment4unknown_status
NCT06327308
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03433508
Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic ShockNo drug interventionstreatmentNot Availablewithdrawn
NCT03091738
Ramelteon for Treatment of Insomnia in Cirrhosistreatment4completed
NCT04786743
Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCTNo drug interventionstreatmentNot Availablerecruiting
NCT02944643
Mindfulness and Support Group to Improve Patient and Caregiver Burden in CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT03846843
OCR002-SP103 - Oral Immediate Release StudyNo drug interventionsbasic_science1completed
NCT00485290
Effect of Meal on Portal and Esophagus Variceal PressureNo drug interventionsbasic_scienceNot Availableterminated
NCT06541990
Psychoeducational Intervention for Patients With Hepatocellular CarcinomaNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05147090
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis Btreatment4recruiting
NCT00058890
Gabapentin to Treat Itch in Patients With Liver Diseasetreatment3completed
NCT01562821
Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomytreatment2completed
NCT05013502
Empagliflozin in Diuretic Refractory Ascitestreatment1completed
NCT02097784
Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney InjuryNo drug interventionsdiagnosticNot Availablecompleted
NCT03513887
Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04244487
Laparoscopic Splenectomy and Azygoportal Disconnection With Intraoperative Endoscopic Variceal LigationNo drug interventionstreatmentNot Availablecompleted
NCT01948687
Real Time Elastography in Liver FibrosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00096733
Adult-to-Adult Living Donor Liver Transplantation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05170854
The Impact of Liver Cirrhosis on Outcomes in Trauma PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00883454
Estimation of Functional Liver Reserve Using CholinesterasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04264754
Characterization of Methylation Patterns in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT01847651
Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartateNo drug interventionstreatment4completed
NCT02776553
A Physical Activity Program in End-state Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskNo drug interventionsNot AvailableNot Availablerecruiting
NCT00534677
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleedtreatment4completed
NCT03225677
Novel Tracer Methods to Evaluate Muscle Protein Metabolism in CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03593447
To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patientstreatment2completed
NCT06184347
Population-wide Research for HBV-related Liver Diseases in Maoming CityNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03631147
The Effect of Rifaximin on Portal Vein ThrombosistreatmentNot Availableunknown_status
NCT00115947
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and AscitesNot Available2 / 3completed
NCT02636647
Fecal Transplant in Recurrent Hepatic EncephalopathyNo drug interventionsother1completed
NCT01157845
Use of Methacetin Breath Test to Predict Liver Failure in Patients With CirrhosisNo drug interventionsdiagnostic3completed
NCT03796598
FMT in Cirrhosis and Hepatic EncephalopathyNo drug interventionsother1 / 2completed
NCT03242798
Assessment of Nutritional Status of Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06458998
Getting To Implementation: Improving Cancer Screening for VeteransNo drug interventionshealth_services_researchNot Availableenrolling_by_invitation
NCT03775798
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.No drug interventionsNot AvailableNot Availableunknown_status
NCT02508298
Surrogate Markers of Portal PressurediagnosticNot Availablecompleted
NCT00188097
Diagnosis of Variceal Bleeding and Its Control in CirrhosisNo drug interventionspreventionNot Availableterminated
NCT01217983
Utility of Renal Biomarkers in CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06061328
Project OASIS: Optimizing Approaches to Select Implementation StrategiesNo drug interventionshealth_services_researchNot Availableenrolling_by_invitation
NCT01231828
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.preventionNot Availablecompleted
NCT00124228
Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitistreatment3completed
NCT01801228
Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effectstreatment2withdrawn
NCT00375011
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in CirrhoticsNo drug interventionsNot AvailableNot Availableterminated
NCT03506893
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT01777971
The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in CirrhosisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01713478
Subclinical Myocardial Dysfunction in Patients With Hepatic CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT01944878
The Association With Peptic Ulcer Disease and Hepatic Vein Pressure GradientNo drug interventionsNot AvailableNot Availablecompleted
NCT02457988
The Cirrhosis Outpatient Optimization, Readmission & Safety StudyNo drug interventionsdiagnostic0terminated
NCT01048788
A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mgtreatment3completed
NCT01196507
Early Primary Prophylaxis of Esophageal VaricespreventionNot Availablecompleted
NCT00005107
Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemiatreatment1unknown_status
NCT06216509
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02026609
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)No drug interventionsNot AvailableNot Availableterminated
NCT00347009
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosistreatment4completed
NCT01676285
Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosistreatment3completed
NCT01095185
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleedingtreatment3completed
NCT05724485
Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosistreatment4completed
NCT01799785
Effects of Aerobic Training on Exercise Capacity in Patients With CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT02275585
Portal Vein Thrombosis in CirrhosisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01884415
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosistreatment3completed
NCT02638415
The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varicesprevention4unknown_status
NCT04899115
VE303 for Treatment of Hepatic Encephalopathy (HE)treatment2completed
NCT00250315
DOCICAR: Cardiac Dysfunction in CirrhosisNot AvailableNot Availablecompleted
NCT05181332
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00760032
Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patientsdiagnostic4withdrawn
NCT03339232
BCAA Supplemental StudyNo drug interventionssupportive_careNot Availablecompleted
NCT01164332
Sensitivity of Alternative NRL972 Detection Methods in Healthy SubjectsNo drug interventionsdiagnostic1completed
NCT03919032
Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological CharacteristicsNo drug interventionsNot AvailableNot Availablecompleted
NCT05726032
Empagliflozin in Patients With Cirrhosis and Ascitesother2recruiting
NCT00162552
Clinical Trial of Pentoxifylline in Patient With Cirrhosistreatment3completed
NCT05548452
Intestinal Microbiota Transplant in Alcohol-Associated Liver DiseaseNo drug interventionstreatment1 / 2recruiting
NCT03311152
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in CirrhosisNo drug interventionsdiagnosticNot Availableunknown_status
NCT01851252
MBT Versus HVPG in Identifying Responders to Portal Hypertension TherapyNo drug interventionssupportive_care1completed
NCT03946852
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03513900
Non-invasive Methods to Predict PHG in CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02319200
Primary Prevention Hepatocellular Carcinoma by Metforminprevention3terminated
NCT00965900
Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleedingprevention4unknown_status
NCT01037959
Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failureprevention3terminated
NCT03948659
Ventriculo-arterial Coupling in CirrhoticsNo drug interventionsNot AvailableNot Availablecompleted
NCT03293459
Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.No drug interventionstreatmentNot Availablecompleted
NCT04675775
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.No drug interventionstreatmentNot Availablecompleted
NCT02925975
Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPSprevention4unknown_status
NCT04006275
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCdiagnostic3unknown_status
NCT03448770
To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.treatmentNot Availableunknown_status
NCT02757170
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using ThromboelastographyNo drug interventionsscreening4unknown_status
NCT04371042
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03085342
Evaluation of Hepatic Fibrosis on Multiparametric MRINo drug interventionsdiagnosticNot Availableunknown_status
NCT05484206
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434treatment1recruiting
NCT00921349
A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosisprevention4completed
NCT01542749
Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume AnalyzerNo drug interventionsNot AvailableNot Availablecompleted
NCT02907749
Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosisprevention4completed
NCT05797649
Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid AnalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00764049
Single Pass Albumin Dialysis in Patients With CirrhosisNo drug interventionstreatment1 / 2completed
NCT04023136
Liver Resection ModelingNo drug interventionsotherNot Availableunknown_status
NCT04509336
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic PatientstreatmentNot Availableterminated
NCT00479336
A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edematreatment2completed
NCT01141036
Propofol Versus Midazolam for Upper Endoscopy in Cirrhotic Patientssupportive_careNot Availablecompleted
NCT00466336
Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesNo drug interventionsNot AvailableNot Availablecompleted
NCT03144713
Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in CirrhosistreatmentNot Availablecompleted
NCT05744713
An Observational Study of Patients With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01807013
Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.No drug interventionsNot AvailableNot Availableunknown_status
NCT01359813
Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitistreatment3terminated
NCT03732118
EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic EncephalopathyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02344719
Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosistreatment4completed
NCT03137719
Infections in Hospitalized Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02056041
Selection Criteria for Safe Hepatectomy for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT02756741
Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial Peritonitisbasic_scienceNot Availablecompleted
NCT02249741
Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementationtreatment4completed
NCT03285217
HMB for Denutrition in Patients With Cirrhosis (HEPATIC)No drug interventionstreatmentNot Availablecompleted
NCT01774617
Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting ListNo drug interventionsNot AvailableNot Availablecompleted
NCT02628717
Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)No drug interventionsNot AvailableNot Availablecompleted
NCT06328517
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive ModelsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00420134
Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical TrialNo drug interventionstreatment1 / 2completed
NCT02533934
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplanttreatment4completed
NCT00713934
Autologous Bone Marrow Stem Cells in Cirrhosis PatientsNo drug interventionstreatment1 / 2completed
NCT04248816
Hepatocellular Carcinoma Surveillance in CirrhoticsNo drug interventionsscreeningNot Availablecompleted
NCT02400216
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00004796
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosistreatment2completed
NCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02016196
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPStreatment3completed
NCT03071458
Mutational Landscape in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT01463735
Vitamin E Supplement in Patients With Cirrhosis and AcanthocytosisNo drug interventionstreatment2completed
NCT00122135
A Culturally Sensitive Values-Guided Aid for End of Life Decision-MakingNo drug interventionshealth_services_researchNot Availablecompleted
NCT03849235
A Pathophysiological Study of the Postprandial Human Liver (PLS)No drug interventionsNot AvailableNot Availablerecruiting
NCT06306963
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular EctasiasNo drug interventionsNot AvailableNot Availablerecruiting
NCT02484963
The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With InsomniatreatmentNot Availablecompleted
NCT00502086
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.No drug interventionstreatment3completed
NCT03069339
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C CirrhosistreatmentNot Availableunknown_status
NCT02837939
Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune DysfunctionNo drug interventionsprevention2 / 3withdrawn
NCT00570622
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosistreatment4completed
NCT05473325
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03059030
Yttrium-90 Radioembolization for Cirrhosis-Associated ThrombocytopeniaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04490330
Screening for Alcohol-related Cognitive Impairments in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05737030
Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiometreatment4recruiting
NCT02009748
Vitamin D Supplementation in Cirrhotic PatientsNo drug interventionstreatment2completed
NCT04994548
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal HypertensionNo drug interventionsNot AvailableNot Availablecompleted
NCT02190357
Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trialtreatment4unknown_status
NCT03472157
A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT03530657
Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ ElastographyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04057326
A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and MalnutritiontreatmentNot Availableunknown_status
NCT01350726
Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT ScanNo drug interventionsNot AvailableNot Availableunknown_status
NCT01820026
Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosistreatment4unknown_status
NCT03368066
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?diagnostic3completed
NCT01408966
Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in CirrhosisNo drug interventionstreatment2completed
NCT03176966
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosissupportive_care4completed
NCT05511766
Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosisprevention2 / 3recruiting
NCT02835365
Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT03030820
Oral Gut Liver Axis in CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT02540382
Comparison of Covered and Bare Stent in TIPSNo drug interventionstreatmentNot Availablecompleted
NCT03069131
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascitestreatment3completed
NCT02113631
Comparative Effectiveness and Tolerability of Boceprevir vs TelaprevirtreatmentNot Availablecompleted
NCT02131831
Telomeres Parameters in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00570973
Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical TherapyNo drug interventionsprevention4completed
NCT06245473
Metobolomics in the Characterisation of HENo drug interventionsNot AvailableNot Availablerecruiting
NCT02389127
Relationship Between HbA1c and Chronic Glycemia in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06133127
Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?No drug interventionsotherNot Availablerecruiting
NCT01960127
Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2No drug interventionstreatmentNot Availablecompleted
NCT06052176
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvementprevention2recruiting
NCT03154476
Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Studyother3completed
NCT04075760
EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV INo drug interventionspreventionNot Availableunknown_status
NCT02528760
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill CirrhosistreatmentNot Availablecompleted
NCT00476060
Mesenchymal Stem Cell Transplantation in Decompensated CirrhosisNo drug interventionstreatment2completed
NCT03965260
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01309594
HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow TransplantationNo drug interventionstreatmentNot Availableunknown_status
NCT00511394
Acute Hemodynamics of Albumin Versus Normal Saline in CirrhosisdiagnosticNot Availablesuspended
NCT04642391
Defining the Mechanisms Underlying Adrenal Insufficiency in CirrhosisNot AvailableNot Availableactive_not_recruiting
NCT00305591
Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.diagnosticNot Availablecompleted
NCT01987791
Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02132962
Sarcopenia and CirrhosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT04925362
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)No drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT05389280
Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02074280
Rifaximin Predicts the Complications of Decompensated Cirrhosisprevention4unknown_status
NCT05835180
A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Functiontreatment1completed
NCT06425380
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic EncephalopathyNo drug interventionstreatment2recruiting
NCT03439189
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14diagnosticNot Availablecompleted
NCT03023189
Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleedingtreatment4unknown_status
NCT06205992
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05061992
A Trial to Improve Quality of Life in People With Cirrhosistreatment2 / 3completed
NCT00154492
Use of NovoSeven® in Active Variceal Bleedingtreatment2completed
NCT01134692
Probiotics for Portal Hypertensionprevention3unknown_status
NCT03837444
Microvesicles and Monocytes to Predict Mortality of Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01669044
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical PatientsNot AvailableNot Availableunknown_status
NCT00059267
Prevention of Recurrent Hepatitis B After Liver TransplantationNot AvailableNot Availablecompleted
NCT01872767
Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT02083367
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT02755701
The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascitestreatment4unknown_status
NCT05201404
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosistreatment3recruiting
NCT02960204
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertensiontreatment2completed
NCT06348004
The Association Between Albumin Administration and Short-term Rebleeding Risk in Cirrhosis Patients With Acute Variceal Hemorrhage and Stable HemodynamicsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02480972
Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT05231772
Probiotics and Hemodynamic Changes in CirrhosistreatmentNot Availablecompleted
NCT04365868
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosisprevention2 / 3active_not_recruiting
NCT03145168
High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill CirrhoticsNo drug interventionstreatmentNot Availablecompleted
NCT00004368
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosistreatment1unknown_status
NCT02298868
Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Studytreatment2completed
NCT04330469
Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled TrialNo drug interventionstreatmentNot Availableunknown_status
NCT06316869
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch ViscoelastographyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06007846
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancertreatment2 / 3recruiting
NCT05538546
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03905746
Study of microRNAs in a Decompensated CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00212212
Selenium Supplementation of Patients With CirrhosisNo drug interventionsdiagnosticNot Availableterminated
NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionNo drug interventionstreatment1active_not_recruiting
NCT02931812
Feeding Behavior and Taste Sensitivity Before and After Liver or Renal TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02968810
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosisprevention2active_not_recruiting
NCT01476995
Prognostic Indicators as Provided by the EPIC ClearViewNo drug interventionsNot AvailableNot Availablecompleted
NCT02271295
Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patientstreatment3suspended
NCT00401895
Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered StentsNo drug interventionsprevention2terminated
NCT02476695
FibroTouch Non-invasive Evaluation of Liver Fibrosis and CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01657695
Hepatocellular Carcinoma Growth and Molecular AggressivenessNo drug interventionsNot AvailableNot Availablecompleted
NCT04650295
Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles TrialNo drug interventionstreatmentNot Availablecompleted
NCT01133795
Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairmenttreatment2completed
NCT00968695
Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.treatment4completed
NCT00163995
Urotensin II and Vascular Tone in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03566914
Tadalafil for Erectile Dysfunction in Patients With CirrhosistreatmentNot Availablecompleted
NCT01607814
Oxidative Stress and Haemostasis Abnormalities in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00222014
TIPS With Coated Stents for Refractory Ascites in Patients With CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT00108355
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosistreatment4completed
NCT01362855
Advance Care Planning Evaluation in Hospitalized Elderly PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01212250
Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in CirrhosispreventionNot Availableunknown_status
NCT06052150
Oral Health In Cirrhosis of the Liver (ORACLE)No drug interventionsNot AvailableNot Availablerecruiting
NCT04807023
Decompensation of Cirrhosis and Iron MetabolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT05118308
EUS vs TJ for Liver Biopsy and Portal Pressure Gradient MeasurementNo drug interventionsdiagnosticNot Availableunknown_status
NCT01434108
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal BleedingNo drug interventionstreatment2 / 3completed
NCT06062108
Prevalence of Pain in Hospitalized Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05157308
A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical ParametersNo drug interventionsNot AvailableNot Availableunknown_status
NCT00517738
Effect of Physical Training Program on Health-related Quality of Life in CirrhosisNo drug interventionsNot Available2completed
NCT04806750
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertensiontreatment2completed
NCT03626090
Mesenchymal Stem Cell Therapy for Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT04975490
Characterization and Pathogenesis of ACLFNo drug interventionsNot AvailableNot Availablerecruiting
NCT04668664
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsNo drug interventionsNot AvailableNot Availablecompleted
NCT05082064
Observational Prospective Study.at the End of the Study the Patients Will be Classified According to PH,Serum Bicarbonate and Serum Sodium Into 6 Groups and Statistical Analysis Will be Performed Using SpssNo drug interventionsNot AvailableNot Availablecompleted
NCT01494064
Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive CareNo drug interventionsNot AvailableNot Availablecompleted
NCT01223664
Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver CirrhosisNo drug interventionstreatment2unknown_status
NCT05856721
Pattern of Intestinal Parasitic Infection Among Cirrhotic Patients in Sohag University HospitalNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT04613921
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03446521
AGRA Before and After Liver TransplantationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02837302
Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Diseasetreatment4unknown_status
NCT00281502
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathytreatment2unknown_status
NCT01233102
Mesenchymal Stem Cells Treat Liver CirrhosisNo drug interventionstreatment1 / 2suspended
NCT05056584
The Role of the Kidneys and Liver in the Elimination of Glucagonbasic_scienceNot Availablecompleted
NCT02019784
Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathybasic_science4completed
NCT05853484
Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00501384
Satavaptan Dose-Ranging Study in the Prevention of Ascitestreatment2completed
NCT04281784
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)No drug interventionssupportive_careNot Availablecompleted
NCT01369979
Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT03633279
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child Ctreatment3active_not_recruiting
NCT06392503
Noninvasive Diagnosis Model for High-risk Varices in CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02526303
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosistreatmentNot Availablewithdrawn
NCT00976287
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver CirrhosisNo drug interventionstreatment2unknown_status
NCT01718587
Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patientstreatment1 / 2unknown_status
NCT05253287
Growth Hormone in Decompensated Liver Cirrhosistreatment2 / 3recruiting
NCT00243633
Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)No drug interventionsdiagnosticNot Availablecompleted
NCT01971333
Dynamic Preload Parameters During Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04812054
Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain DeathNo drug interventionspreventionNot Availableunknown_status
NCT00689754
Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal BleedNo drug interventionsdiagnosticNot Availablecompleted
NCT01905254
Transient Elastography in Autoimmune HepatitisNo drug interventionsdiagnosticNot Availablecompleted
NCT00935454
Hepatocyte Matrix Implant StudyNo drug interventionstreatment1unknown_status
NCT03995251
Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.treatmentNot Availableunknown_status
NCT00304551
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)treatment3completed
NCT01897051
Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patientstreatment2 / 3unknown_status
NCT05513651
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPTNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01380951
Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)treatment4unknown_status
NCT05596253
Incidence and Predictors of Post-TIPS Heart Failure in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02957253
Effects on Liver Cirrhotic Patients' by a Nurse-led ClinicNo drug interventionssupportive_careNot Availablecompleted
NCT03580577
Risk Factors and Outcomes of Acute Venous Thromboembolism in CirrhoticNo drug interventionsNot AvailableNot Availableunknown_status
NCT00273247
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosistreatment3completed
NCT01470547
Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT05490147
Effect of Low Tidal Ventilation on Intraoperative Bleeding in Laparoscopic Major HepatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT05939947
A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosisbasic_science1recruiting
NCT02693847
Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06069947
SALT for Liver Cirrhosis With HCCNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03391245
Vitamin D Level and Risk of Infections in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01282398
Study About Simvastatin in Portal Hypertension in Compensated Cirrhosisprevention4unknown_status
NCT04207398
TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary ProphylaxisNo drug interventionspreventionNot Availableunknown_status
NCT00956098
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosistreatment2completed
NCT04406298
Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory AscitesNo drug interventionstreatmentNot Availableunknown_status
NCT05502198
Relevance of Sarcopenia in Advanced Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03263598
Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With AscitesNo drug interventionsNot AvailableNot Availablecompleted
NCT03414398
Assessing Cirrhosis Quality of Care While Accounting for CostNo drug interventionsNot AvailableNot Availableunknown_status
NCT05667805
Coagulation in Cirrhosistreatment4recruiting
NCT01724697
Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT00562783
A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated CirrhosisNo drug interventionstreatment2completed
NCT05302661
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT01002261
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT02926261
Methods for Nutritional Assessment in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00006161
Decompression Intervention of Variceal Rebleeding Trial (DIVERT)No drug interventionstreatment3completed
NCT00168961
Enteral Nutrition in Liver CirrhosisNo drug interventionsNot Available4completed
NCT02802228
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patientstreatment2completed
NCT01333228
Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver CirrhosisNo drug interventionstreatment1 / 2completed
NCT04448028
Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trialprevention4recruiting
NCT01607528
Influence of Probiotics on Infections in CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT02475928
Zinc Supplementation in Cirrhotic PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT03571711
Meropenem Pharmacokinetics in Spontaneous Bacterial PeritonitisNot AvailableNot Availableunknown_status
NCT05387811
International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI ProjectNot AvailableNot Availablecompleted
NCT06050993
Effects of Platelet Mimicking Nanoparticles in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00039871
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)treatment3completed
NCT00978978
Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver DiseaseNot AvailableNot Availableunknown_status
NCT00358878
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)treatment3completed
NCT02362178
Thromboelastographic Guide for Blood Products in CirrhoticsNo drug interventionstreatment2completed
NCT03590288
Dynamic Monitor of Portacaval Pressure GradientNo drug interventionsNot AvailableNot Availablecompleted
NCT01728688
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT02439307
Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal BacterialtreatmentNot Availableterminated
NCT01355107
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01951209
Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosisbasic_scienceNot Availableterminated
NCT01904409
Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosisprevention2completed
NCT04414956
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular CarcinomaNo drug interventionsscreeningNot Availablerecruiting
NCT06092385
SASL Swiss Cirrhosis CohortNo drug interventionsNot AvailableNot Availablerecruiting
NCT01282385
Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertensionprevention4unknown_status
NCT02311985
Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical TrialNo drug interventionstreatmentNot Availableterminated
NCT01389115
Fatty Acids Lipidome and Oxidative Stress in Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05542615
Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).treatment2recruiting
NCT03673215
The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairmenttreatment0unknown_status
NCT05641337
Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetestreatment3recruiting
NCT06144437
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT06022237
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.treatmentNot Availablenot_yet_recruiting
NCT06256432
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrometreatment2recruiting
NCT02849132
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patientstreatment4active_not_recruiting
NCT03721952
Facilitating Communication StudyNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04329559
COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00592475
A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patientstreatment2completed
NCT01619475
Adult-to-Adult Living Donor Transplant Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02221570
Baclofen in the Treatment of Muscle Cramps in Patients With CirrhosistreatmentNot Availableunknown_status
NCT04809870
Esophagectomy in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04494542
Sustained Low Efficiency Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury in Critically Ill CirrhoticsNo drug interventionstreatmentNot Availablecompleted
NCT05960006
A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02767206
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.No drug interventionsNot AvailableNot Availableunknown_status
NCT01503749
Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosistreatment1completed
NCT05895136
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).treatment2recruiting
NCT01842113
Quality of Life and Nutritional Improvements in Cirrhotic Patientstreatment4terminated
NCT05055713
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With HypersplenismNo drug interventionstreatmentNot Availableunknown_status
NCT04789213
Mortality, Morbidity and Risk Factors of Liver RetransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT05335213
Urinary Tract Infections in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02178319
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled TrialNo drug interventionstreatmentNot Availableunknown_status
NCT00687219
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)treatment3completed
NCT00993941
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal VeinNo drug interventionstreatment2unknown_status
NCT04539717
FAST (Focused Abbreviated Screening Technique)-MRI StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00488917
Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)No drug interventionsNot AvailableNot Availablecompleted
NCT02038517
Cirrhosis, Effects of TRAnsplantation and DiabetesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06129617
Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver DysfunctionNo drug interventionstreatmentNot Availablerecruiting
NCT01943617
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosistreatment4completed
NCT06147934
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT06084234
National Liver Cancer Screening TrialNo drug interventionsscreening4recruiting
NCT04850534
Systemic Inflammation in Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05699824
To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C CirrhosistreatmentNot Availablerecruiting
NCT03202524
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesistreatment4withdrawn
NCT00344916
Phase 1 Study of L-NMMA in Patients With Liver CirrhosisNot Available1completed
NCT01150916
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related AscitesNo drug interventionsdiagnosticNot Availablecompleted
NCT02120196
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitisprevention3unknown_status
NCT06101758
Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER StudyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02073435
A2ALL-Patients Safety System Improvements in Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT06380335
Study in Patients With Decompensated Liver CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03996135
Evaluation of Accuvein in Cirrhotics PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT02785835
Hepatocellular Carcinoma in HIV-infected PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03748563
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT03269786
Changes in Lab and Ultrasonography After Endoscopic Varisceal TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT00212186
Selenium Supplementation of Patients With CirrhosisNot AvailableNot Availablecompleted
NCT03209986
Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT02798939
Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT02418039
High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic EncephalopathyNo drug interventionstreatmentNot Availableterminated
NCT02702739
Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patientstreatment4completed
NCT02385422
The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleedingprevention4unknown_status
NCT02325622
Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous DiabetesNo drug interventionsNot AvailableNot Availableunknown_status
NCT01025622
Intrahepatic Reinfusion of CD133+ Stem Cells in Cirrhotic PatientsNo drug interventionstreatment1unknown_status
NCT00501722
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascitestreatment2completed
NCT01045525
Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic LiversiderosisNo drug interventionstreatment3completed
NCT03022630
Palliative Care for Non-Malignant Diseases (COMPASS Trial)No drug interventionssupportive_careNot Availableterminated
NCT05677230
To Compare the Safety and Efficacy of Balloon Occluded/Plug Assisted Retrograde Transvenous Obliteration With Endoscopic Variceal Obturation for Primary Prophylaxis of Gastric Varices With Large Spontaneous ShuntNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02692430
The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).No drug interventionsNot AvailableNot Availableunknown_status
NCT01433848
Prospective Analysis Of Cardiac Function In Cirrhotic Patients By Echocardiography And Its Correlation With EventsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01762748
Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplantsupportive_care2completed
NCT02415348
The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac PacemakersNo drug interventionsdiagnosticNot Availableunknown_status
NCT02421848
Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXANo drug interventionsNot AvailableNot Availablecompleted
NCT05120557
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASHNo drug interventionsdiagnosticNot Availableunknown_status
NCT05181826
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02853526
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPVtreatment3unknown_status
NCT02134626
Simvastatin Effect on Portal Hypertensiontreatment3completed
NCT00501566
Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascitestreatment2completed
NCT04826666
Intraoperative Phlebotomies and Bleeding in Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT06161766
Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal DiseaseNot AvailableNot Availablerecruiting
NCT05080465
Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver CirrhosisNo drug interventionsother3active_not_recruiting
NCT01938820
Optimized Treatment and Regression of HBV-induced Early Cirrhosistreatment4completed
NCT01494220
Validation of the Bispectral Index Monitor During Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT04727320
The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.treatment0unknown_status
NCT02542020
Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06150482
Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05971082
Risk Factors for Advanced Fibrosis Among FLD PatientsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04076631
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00469131
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroidtreatment3completed
NCT03171727
Low Molecular Weight Heparin for the Prevention of Early TIPS DysfunctiontreatmentNot Availableunknown_status
NCT01728727
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT00232427
PiCCO Guided Therapy in Liver CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT02710227
Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01224327
Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis PatientsNo drug interventionstreatment1 / 2unknown_status
NCT00763776
Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic DissectorNo drug interventionstreatmentNot Availableterminated
NCT03482076
Iron Deficiency Anemia in Childern With Liver CirrhosisNo drug interventionsdiagnosticNot Availableunknown_status
NCT04048876
Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosistreatment2terminated
NCT02448160
Alfapump-albumin Replacement TherapytreatmentNot Availableterminated
NCT01271660
A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosistreatment3completed
NCT00628160
Terlipressin in Septic Shock in Cirrhosistreatment2 / 3completed
NCT06457360
Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Childrentreatment0completed
NCT05596760
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their CaregiversNo drug interventionssupportive_careNot Availablerecruiting
NCT02889094
French HIV-HBV CohortNo drug interventionsNot AvailableNot Availableunknown_status
NCT01288794
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosistreatment4completed
NCT05869591
DOAC in Patients With Child A or B Liver Cirrhosisother2recruiting
NCT06496191
FMT for Alcohol Use Disorder in Cirrhotics.No drug interventionstreatmentNot Availablerecruiting
NCT02239991
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver TransplantNo drug interventionstreatmentNot Availableunknown_status
NCT01735591
Administration of Probiotics in Cirrhotic Patients Listed for Liver TransplantationNo drug interventionspreventionNot Availablecompleted
NCT01147380
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver TransplantationNo drug interventionstreatment1completed
NCT03318380
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT02335580
Effect of Portal Vein Thrombosis on the Prognosis of Liver CirrhosisNot AvailableNot Availablecompleted
NCT01108380
Evaluation of Liver Regeneration With Autologous Peripheral Stem CellsNo drug interventionstreatmentNot Availableunknown_status
NCT05719480
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03080129
Microbiome and Sarcopenia in Patients With Liver CirrhosisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT01804829
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.prevention3completed
NCT02023229
Branched Chain Aminoacid Supplementation in Patients With Liver CirrhosisNo drug interventionstreatment4completed
NCT06469489
Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05989789
Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT03470389
Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM)No drug interventionsdiagnosticNot Availableunknown_status
NCT04397289
Anticoagulation Therapy After Splenectomy in Cirrhosis Patientprevention1 / 2completed
NCT00679692
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04109144
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesistreatment2withdrawn
NCT01769040
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosisbasic_science4completed
NCT00470340
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patientsprevention3terminated
NCT02047240
Renal Function Determination in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01501240
Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic LiverNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02297867
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver CirrhosisNo drug interventionstreatment1completed
NCT06026267
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial PeritonitistreatmentNot Availablerecruiting
NCT00811967
Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)treatment3terminated
NCT01113567
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic EncephalopathyNo drug interventionstreatmentNot Availableterminated
NCT04578301
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT01002001
Sleep Disorders Pre and Post Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05250401
Thyroid Function in Liver Cirrhosis: Is it Affected?No drug interventionsNot AvailableNot Availablecompleted
NCT03092401
Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03584204
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and OutcomeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00748904
Rifaximin Versus Lactulose in Renal Failuretreatment4withdrawn
NCT05741372
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisotherNot Availablerecruiting
NCT06265272
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver CirrhosisNot AvailableNot Availablerecruiting
NCT02787772
Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?No drug interventionssupportive_careNot Availablecompleted
NCT05106972
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B CirrhosisNo drug interventionstreatmentNot Availablerecruiting
NCT04819568
Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.treatmentNot Availableunknown_status
NCT04828369
Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With ShuntNo drug interventionsNot AvailableNot Availablecompleted
NCT05466669
Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05094869
Prevention of HCC Using Mobile Phone ApplicationsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04794946
Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver CirrhosistreatmentNot Availableunknown_status
NCT01071746
Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)No drug interventionsNot AvailableNot Availableunknown_status
NCT04621812
Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.No drug interventionsNot AvailableNot Availableunknown_status
NCT04437810
To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI DevelopmenttreatmentNot Availableunknown_status
NCT04890210
Initiation of Diet in Esophageal Varices After Ligation (IDEAL) StudyNo drug interventionssupportive_careNot Availableunknown_status
NCT02602210
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsistreatment3terminated
NCT03892681
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05095181
To Study the Effects of Host Genetic Factors on Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04806581
Clinical Study of Hepatocyte Transplantation for Liver CirrhosisNo drug interventionstreatment1not_yet_recruiting
NCT02423395
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosistreatment3recruiting
NCT01629095
Genetic Studies of Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT03228095
Volatiles in Breath and Headspace Analysis - Diagnostic MarkersNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02630095
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCTtreatment4unknown_status
NCT01558895
Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory AscitesNo drug interventionstreatment2 / 3unknown_status
NCT06153914
SALT for Patients With Hepatic CirrhosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05848414
Short Term Outcomes in Hospitalized Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05457114
Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT06114355
Comparison of Pre-operative EUS Guided and Intra-operative Direct Portal Vein Pressure Measurement in Pretransplant CirrhoticsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04644055
EUS Share-wave in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03957655
Safety and Efficacy of SHED for Decompensated Liver CirrhosisNo drug interventionstreatment0unknown_status
NCT05786755
Compositional Shift of Gut Microbiome According to the Complications in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04969055
Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT06206655
Diagnosis of Adrenal Insufficiency in Liver Cirrhosis PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02022150
Body Composition Analysis in Cirrhotic Undergoing ParacentesisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05342350
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04874350
A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaNo drug interventionstreatment2completed
NCT04782050
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationNo drug interventionsdiagnosticNot Availablecompleted
NCT01062750
Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal CellsNo drug interventionstreatmentNot Availablecompleted
NCT04896723
Sexual Dysfunction in Patients With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05060523
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)treatmentNot Availableunknown_status
NCT02508623
Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varicestreatment3unknown_status
NCT03587623
Copeptin Serum Level in Liver Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03241823
Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.No drug interventionsNot AvailableNot Availableunknown_status
NCT04489108
Tranexamic Acid for Acute Upper Gastrointestinal Bleed in CirrhosistreatmentNot Availableunknown_status
NCT01423708
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Studytreatment2unknown_status
NCT02556138
Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist CandidatesNo drug interventionssupportive_careNot Availableterminated
NCT06082843
A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Bellytreatment2terminated
NCT06384443
Proton Pump Inhibitors in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05376943
Possible Differences in HCC Course Depending on DAA TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT04863703
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Not AvailableNot Availablerecruiting
NCT01495403
Treatment of Muscle Cramps in Patients With Liver Cirrhosissupportive_care0completed
NCT03342703
Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRINo drug interventionsNot AvailableNot Availablecompleted
NCT02023190
Changes in Body Composition and Nutritional Status in Patients Undergoing Liver TransplantationNo drug interventionsNot AvailableNot Availableunknown_status
NCT01618890
Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal BleedingNo drug interventionstreatment3unknown_status
NCT01598064
Probiotics for Liver Cirrhosis With Portal HypertensionNo drug interventionspreventionNot Availablecompleted
NCT04391764
Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.treatmentNot Availablecompleted
NCT04012021
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRINo drug interventionsbasic_scienceNot Availableunknown_status
NCT03729921
Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric VaricesNo drug interventionspreventionNot Availableunknown_status
NCT06478602
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosistreatment3recruiting
NCT02642484
Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosistreatment3unknown_status
NCT02485184
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein ThrombosistreatmentNot Availablerecruiting
NCT01298284
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranololtreatment4unknown_status
NCT06269484
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKtreatment2recruiting
NCT02468479
Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02321579
Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant CapacitiesNo drug interventionspreventionNot Availableunknown_status
NCT01091233
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational StudyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03675633
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05185154
Natural Course and Prognosis of Hospitalized Patients With CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04494451
Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.treatmentNot Availablecompleted
NCT05378451
Totally Extraperitoneal Repair of Groin Hernia in Liver Transplanted PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02343653
The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT02021253
Influence of Probiotics Administration Before Liver Resection in Liver DiseaseNo drug interventionsotherNot Availablecompleted
NCT05386953
Intraoperative Normal Saline Administration and Acute Kidney Injury in Patients Undergoing Liver TransplantationNot AvailableNot Availableunknown_status
NCT04932577
Faecal Microbiota Transplantation for Liver CirrhosisNo drug interventionstreatment2 / 3recruiting
NCT06561477
Role of ICCO Score in Predicting Outcome in ICU PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05674877
Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resectionsupportive_care3completed
NCT02024347
A New Screening Strategy for VaricesNo drug interventionsNot AvailableNot Availablecompleted
NCT06147947
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT01560845
ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver CirrhosisNo drug interventionstreatment2 / 3unknown_status
NCT06091345
Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and AscitestreatmentNot Availablenot_yet_recruiting
NCT06279845
A Clinical Cohort Study on the Pathogen Spectrum of Hepatic Virus-caused Cirrhosis Complicated With InfectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03337945
In Vivo Determination of Cytochrome P450 Activities in Patients With Liver CirrhosisNo drug interventionsdiagnosticNot Availablecompleted
NCT05516498
Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)screening2recruiting
NCT00006398
Prevention of Esophageal Varices by Beta-Adrenergic Blockersprevention3completed
NCT03202498
Safety and Tolerability of Yaq-001 in Patients With CirrhosisNo drug interventionsdevice_feasibilityNot Availableterminated
NCT03345498
Entecavir for Decompensated HBV CirrhosisNot AvailableNot Availablecompleted
NCT02949505
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT00540397
TCM Etiological Study on the Theory of XuSunShengJi in Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT01767597
Application of HBV Rapid Tests as a Tool for Wide-Use ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT01492283
Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without DiabetesNo drug interventionsNot AvailableNot Availablecompleted
NCT05515861
Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric VaricesNo drug interventionspreventionNot Availableunknown_status
NCT02642861
Cyclobenzaprine in Muscle Cramps With Liver Cirrhosistreatment3unknown_status
NCT03530761
Korean Cohort Study of AKI & HRS in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06544161
EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin SubstitutionNo drug interventionsotherNot Availablerecruiting
NCT06583161
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)No drug interventionsNot AvailableNot Availablecompleted
NCT01361061
AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the LiverNo drug interventionsNot AvailableNot Availablecompleted
NCT04553328
Ultrasound-guided Ipsilateral Transverse Abdominis Plane and Ilioinguinal Iliohypogastric Nerve Block.No drug interventionsotherNot Availablecompleted
NCT04874428
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosisbasic_science1unknown_status
NCT02695628
[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancerdiagnostic2completed
NCT01097811
Comparison Between Erythromycin and Neomycin Treatment of Hepatic EncephalopathytreatmentNot Availableunknown_status
NCT05088811
The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT05658393
Web-based Mobile Health Application for Patients With Liver Cirrhosis (ReLiver-N App)No drug interventionssupportive_careNot Availablerecruiting
NCT01872793
Validation of BIVA for Nutritional Assessment in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01298271
A Randomized Trial of GVS Alone vs. Propranololtreatment4recruiting
NCT02125071
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00382278
Safety Study of Autologous Stem Cell in Liver CirrhosisNo drug interventionstreatment1 / 2terminated
NCT04949178
Impact of Continuous Renal Replacement Therapy on Systemic Hemodynamics and Lactate Clearance in Critically Ill Cirrhotics With Septic Shock.No drug interventionsNot AvailableNot Availableunknown_status
NCT01909778
Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosistreatment1completed
NCT03459378
Outcome After TIPSNo drug interventionsNot AvailableNot Availablecompleted
NCT02508688
Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic HydrothoraxNo drug interventionstreatmentNot Availablecompleted
NCT02996188
Acute Hemodynamic Changes During ParacentesisNo drug interventionsNot AvailableNot Availablecompleted
NCT02119988
TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT03405909
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05899309
Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05782556
Freiburg TIPS RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT06337656
Vibration Training Approach in Liver CirrhosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00709085
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availableunknown_status
NCT05741385
A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver CirrhosisotherNot Availablerecruiting
NCT05187715
To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.treatmentNot Availableunknown_status
NCT03267615
VICIS - Vienna Cirrhosis StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06338215
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and MortalityNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT01942915
Umbilical Cord Blood Mononuclear Cells Therapy in Liver CirrhosisNo drug interventionstreatment1unknown_status
NCT02022137
Fructans, Lactitol and Lactose in Minimal Hepatic EncephalopathyNo drug interventionstreatmentNot Availablecompleted
NCT00359437
Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Livertreatment3terminated
NCT00831337
Evaluation of Probiotics in the Treatment of Portal HypertensionNo drug interventionspreventionNot Availablecompleted
NCT02695732
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleedingtreatment4unknown_status
NCT02011932
Prospective Observational Study of Disease Progression in Chronic Hepatitis CNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02156232
Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic EncephalopathyNo drug interventionspreventionNot Availablecompleted
NCT04533932
Endosonographic Shear Wave Elastography for Liver StiffnessNo drug interventionsNot AvailableNot Availableunknown_status
NCT06041932
Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior DecompensationtreatmentNot Availablenot_yet_recruiting
NCT04932200
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03694600
Clinical Trial Multi-analyte Blood TestNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01499459
Autologous Mesenchymal Stem Cell Transplantation in Liver CirrhosisNo drug interventionstreatmentNot Availableunknown_status
NCT05199259
Multi-analyte Blood Test Clinical TrialNo drug interventionsNot AvailableNot Availablerecruiting
NCT01877759
A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT02669875
Serelaxin To Lower Portal Pressuretreatment2completed
NCT01151475
Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)No drug interventionsNot AvailableNot Availablecompleted
NCT02705742
Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV HepatitisNo drug interventionstreatment1 / 2unknown_status
NCT00465842
Protein Biomarker in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT05756699
Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02593799
Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00378599
Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)treatment3completed
NCT03161106
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.treatmentNot Availablewithdrawn
NCT05021406
Extension Study of Carvedilol RCT StudypreventionNot Availablerecruiting
NCT01846949
Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)No drug interventionsNot AvailableNot Availableunknown_status
NCT04443049
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.treatmentNot Availableunknown_status
NCT01081236
Intestinal Barrier Function and Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05208736
A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02923336
Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of CirrhoticsdiagnosticNot Availableunknown_status
NCT00678613
Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trialprevention2 / 3unknown_status
NCT04058613
Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With AscitesNo drug interventionssupportive_careNot Availableunknown_status
NCT03114813
Can MRI Evaluate Beta-blocker Response in Portal Hypertension?Not AvailableNot Availableunknown_status
NCT01943318
Boramae Hospital Liver Cirrhosis Patient Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01082419
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver ElasticityNo drug interventionsdiagnosticNot Availablecompleted
NCT02612519
Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of AscitesNo drug interventionstreatmentNot Availableterminated
NCT00849641
Muscle Tissue Oxygenation in Patients With Decompensated Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02377141
Early Use of TIPSS in Patients With Cirrhosis and Variceal BleedingNo drug interventionstreatmentNot Availablecompleted
NCT05104541
Impact of Weight Loss in Cirrhosis With Obesity and MAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT03723317
Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant SurvivalNo drug interventionsNot AvailableNot Availablecompleted
NCT00381017
Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)treatment3withdrawn
NCT04113317
Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantationsupportive_care3completed
NCT04688034
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia.treatment1completed
NCT04184934
Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal HemorrhageNo drug interventionsNot AvailableNot Availableunknown_status
NCT06576934
Early TIPS in Patients With Liver Cirrhosis and AscitesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04987034
Comparing a Direct Versus an Indirect Approach to Measuring the Portalsytemic Pressure GradientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04421924
Periinterventional Coagulation Management of Patients Undergoing a TIPSNo drug interventionsdiagnosticNot Availablerecruiting
NCT02405416
Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad ClampingNo drug interventionstreatmentNot Availableunknown_status
NCT03322696
ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)No drug interventionsNot AvailableNot Availableunknown_status
NCT04088058
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver CirrhosisNo drug interventionstreatment2recruiting
NCT00287235
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)No drug interventionstreatmentNot Availablecompleted
NCT05008263
Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06144086
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)treatment2recruiting
NCT04158986
Nurse Assisted Post-discharge Intervention in Decompensated CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT01456286
Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertensiontreatment2 / 3completed
NCT04842539
Fecal Microbiota Transplantation in Decompensated CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT02226939
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis Ctreatment2completed
NCT01236339
Early TIPS for Ascites StudyNo drug interventionstreatmentNot Availableterminated
NCT04711122
Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver CirrhosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05641025
Prediction of Multidrug-resistant Bacterial Infection in Patients With CirrhosisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03479125
Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or PlaceboNo drug interventionsNot AvailableNot Availableterminated
NCT02899325
FDGal PET/CT to Detect Hepatocellular CarcinomaNot AvailableNot Availablewithdrawn
NCT05807425
Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver CirrhosisNo drug interventionstreatment2 / 3recruiting
NCT01120925
Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic PatientsNo drug interventionstreatment1 / 2completed
NCT06076330
Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced HypotensiontreatmentNot Availablenot_yet_recruiting
NCT01937130
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLFtreatment2terminated
NCT00245830
Ischemic Preconditioning of Liver in Cadaver DonorsNo drug interventionstreatmentNot Availablecompleted
NCT01143948
Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trialtreatment4unknown_status
NCT04724148
Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal HypertensiontreatmentNot Availablerecruiting
NCT01483248
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosistreatment1 / 2unknown_status
NCT05433948
Diagnosing Minimal Hepatic EncephalopathyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02069457
Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02398357
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosistreatment4unknown_status
NCT06312826
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High RiskNo drug interventionsscreeningNot Availablerecruiting
NCT02975726
Peritoneal Dialysis Catheters for the Treatment of Refractory AscitestreatmentNot Availablecompleted
NCT00006166
North American Study for the Treatment of Refractory Ascites (NASTRA)No drug interventionstreatment3completed
NCT02642874
Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patientstreatment3unknown_status
NCT05360420
Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical ProcedureNo drug interventionsdiagnosticNot Availablerecruiting
NCT01201720
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"No drug interventionstreatmentNot Availablecompleted
NCT06014320
Alterations in Coagulation Factor Levels in Patients With End Stage Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06153082
Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.No drug interventionstreatmentNot Availablerecruiting
NCT01006031
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4treatment2 / 3completed
NCT05036031
Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03175731
PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)No drug interventionstreatment4completed
NCT01265173
Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LCtreatment4completed
NCT02335073
Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03989973
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06047327
EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver DiseaseNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT03130127
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosistreatmentNot Availablenot_yet_recruiting
NCT01532427
ALFApump System Post Marketing Surveillance RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT00816127
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental ExtractiontreatmentNot Availablecompleted
NCT05061576
Instructed Home-based Physical Exercise for Patients With Liver CirrhosisNo drug interventionssupportive_careNot Availablerecruiting
NCT04787276
Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic EncephalopathytreatmentNot Availablecompleted
NCT05397860
Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT03623360
Functional MRI to Determine Severity of CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04283994
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)No drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03509194
Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver InsufficiencyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01013194
Human Fetal Liver Cell Transplantation in Chronic Liver FailureNo drug interventionstreatment1 / 2completed
NCT01509391
Keyhole Limpet Hemocyanin in Chronic Hepatitis CtreatmentNot Availablecompleted
NCT01751191
HVPG for Rebleeding Risk StratificationNo drug interventionsNot AvailableNot Availablecompleted
NCT00822991
Sonazoid Enhanced Liver Cancer Trial for Early DetectionNo drug interventionsdiagnosticNot Availableunknown_status
NCT04140591
Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosistreatment2 / 3terminated
NCT03933891
Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPSNo drug interventionsNot AvailableNot Availablerecruiting
NCT01686880
Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic LiverNo drug interventionstreatment2terminated
NCT04823780
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04173429
Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosistreatment4completed
NCT00913289
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal CellsNo drug interventionstreatment1terminated
NCT02943889
Stem Cell Transplantation in Cirrhotic PatientsNo drug interventionstreatment1 / 2unknown_status
NCT05672589
To Compare Relaxed Rotational Thromboelastometry Cut-offs With Standard Cut-offs for Guiding Blood Product Use Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT01220492
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver CirrhosisNo drug interventionstreatment1 / 2completed
NCT06169592
Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00296244
Steroid Free Immunosuppression in Liver Transplantationtreatment4completed
NCT03005444
Anticoagulation for Advanced Cirrhotic Patients After TIPStreatmentNot Availablerecruiting
NCT00965744
A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal HypertensionNo drug interventionstreatment4completed
NCT06031740
A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal HemorrhoidsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01850940
Efficacy and Safety of Tolvaptan in Cirrhotic Patients With HyponatremiaNot AvailableNot Availablecompleted
NCT00337740
Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleedingprevention3terminated
NCT04816240
Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.treatmentNot Availableunknown_status
NCT01894867
Magnesium in Liver CirrhosisNo drug interventionstreatment4unknown_status
NCT01311167
Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasonetreatment3terminated
NCT05012501
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03158701
Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01198704
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT00332904
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosistreatment4unknown_status
NCT04771104
The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver CirrhosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT05331872
Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver CirrhosisNo drug interventionstreatment1completed
NCT05057572
Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal VaricestreatmentNot Availableunknown_status
NCT01335568
Hepatocyte Matrix Implant Study IndonesiaNo drug interventionstreatment1unknown_status
NCT02048969
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRSbasic_science1 / 2withdrawn
NCT01379469
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiencytreatment2terminated
NCT02407769
Late Evening Supplementation With Branched Chain Amino Acids in Liver TransplantationNo drug interventionstreatmentNot Availableunknown_status
NCT03059446
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitistreatment2terminated
NCT05431946
Palliative Care for Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01543646
Multiparametric MR for Rapid Imaging Assessment of the LiverNo drug interventionsNot AvailableNot Availableunknown_status
NCT02470546
Metformin Experience on Minimal Hepatic Encephalopathytreatment4unknown_status
NCT04399512
Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT02987712
Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive ProceduresNo drug interventionstreatmentNot Availableunknown_status
NCT04828512
Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02859610
Microparticles in Cirrhosis and Portal HypertensionNo drug interventionsbasic_scienceNot Availablecompleted
NCT00245310
Indocyangreen Elimination in Cirrhosis and Acute Liver FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT05333510
A Comparative Evaluation of TEG Versus ROTEM for Coagulopathy CorrectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00312910
Probiotics for the Prevention of Major Complications of CirrhosisNo drug interventionspreventionNot Availablecompleted
NCT00857181
Cytokines and the Risk of Infection in Liver CirrhosisNo drug interventionsNot AvailableNot Availableterminated
NCT04433481
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein ThrombosistreatmentNot Availableunknown_status
NCT03460795
Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver DiseaseNo drug interventionstreatment1 / 2not_yet_recruiting
NCT00366795
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Livertreatment3terminated
NCT01518595
Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosistreatment2terminated
NCT02256514
Open Label Trial of Immunotherapy for Advanced Liver Cancertreatment2unknown_status
NCT01201655
Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT01342250
Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver CirrhosisNo drug interventionstreatment1 / 2completed
NCT01421550
Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver CirrhosisNo drug interventionstreatment3unknown_status
NCT05690750
Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.No drug interventionsNot AvailableNot Availablerecruiting
NCT04273750
RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT02551250
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver CirrhosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04640350
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastographyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04639323
Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)No drug interventionsNot AvailableNot Availablerecruiting
NCT03731923
Abbreviated MRI for HCC SurveillanceNo drug interventionsotherNot Availableactive_not_recruiting
NCT01358123
Value of Von Willebrand Factor in Portal HypertensionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01573923
Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver CirrhosisNo drug interventionstreatment1 / 2unknown_status
NCT06121908
Role of Blood Lactate Level in Prediction of Outcome of Cirrhotic Patients at The Intensive Care UnitNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02311608
Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsNot AvailableNot Availableunknown_status
NCT06461208
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisNo drug interventionsprevention3recruiting
NCT02917408
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China HospitalNo drug interventionsNot AvailableNot Availablecompleted
NCT05971108
Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCCNo drug interventionsdiagnosticNot Availablerecruiting
NCT03753438
Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) CirrhoticsNo drug interventionsNot AvailableNot Availablecompleted
NCT01720238
Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver CirrhosisNot AvailableNot Availableunknown_status
NCT01773538
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time MeasurementdiagnosticNot Availablecompleted
NCT05457543
Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function TestsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00147043
Adult Stem Cell Therapy in Liver InsufficiencyNo drug interventionstreatmentNot Availablecompleted
NCT00004641
A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosisprevention2completed